Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:protocol:olmesartan [06.01.2019] – [Related publications and presentations] sallieqhome:protocol:olmesartan [04.10.2020] – [Safety of olmesartan] sallieq
Line 1: Line 1:
    
 ====== Science behind olmesartan (Benicar)     ====== ====== Science behind olmesartan (Benicar)     ======
 +
 +
 +<relatedarticle> [[home:food:aim_health:aging|Health maintenance and Olmesartan]] </article>
  
 Patients on the [[home:protocol|Marshall Protocol]] (MP) take olmesartan (Benicar), a drug whose actions are well known, [[home:mp:olmesartan:dosing|every six hours]].  In general, olmesartan tends to be prescribed for its antihypertensive properties due to the fact that is an angiotensin receptor blocker. A growing body of research supports the use of olmesartan as a part of a curative therapy for chronic disease.  Patients on the [[home:protocol|Marshall Protocol]] (MP) take olmesartan (Benicar), a drug whose actions are well known, [[home:mp:olmesartan:dosing|every six hours]].  In general, olmesartan tends to be prescribed for its antihypertensive properties due to the fact that is an angiotensin receptor blocker. A growing body of research supports the use of olmesartan as a part of a curative therapy for chronic disease. 
Line 16: Line 19:
 Ample research supports the fact that olmesartan is one of the safest and has the most gentle side effects profiles of almost any drug on the market. Ample research supports the fact that olmesartan is one of the safest and has the most gentle side effects profiles of almost any drug on the market.
  
 +For those with gastric issues, it is recommended that the pill be crushed and mixed with applesauce or similar to reduce impact on gastric lining
    
 ===== Potent anti-inflammatory ===== ===== Potent anti-inflammatory =====
Line 134: Line 137:
  
 ==== Cardiovascular disease ==== ==== Cardiovascular disease ====
 +
  
 <blockquote>Several prospective, randomized studies show vascular benefits with olmesartan medoxomil: reduced progression of coronary atherosclerosis in patients with stable angina pectoris (OLIVUS); decreased vascular inflammatory markers in patients with hypertension and micro- (pre-clinical) inflammation (EUTOPIA); improved common carotid intima-media thickness and plaque volume in patients with diagnosed atherosclerosis (MORE); and resistance vessel remodeling in patients with stage 1 hypertension (VIOS). <blockquote>Several prospective, randomized studies show vascular benefits with olmesartan medoxomil: reduced progression of coronary atherosclerosis in patients with stable angina pectoris (OLIVUS); decreased vascular inflammatory markers in patients with hypertension and micro- (pre-clinical) inflammation (EUTOPIA); improved common carotid intima-media thickness and plaque volume in patients with diagnosed atherosclerosis (MORE); and resistance vessel remodeling in patients with stage 1 hypertension (VIOS).
home/protocol/olmesartan.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.